IP Library Granted Patent US 9,447,452
Granted Patent B2
US 9,447,452 · App. 13/795,739 · Granted Sep 20, 2016

Selective oxidation of 5-methylcytosine by TET-family proteins

Inventors: Anjana Rao (La Jolla, CA); Mamta Tahiliani (New York, NY); Kian Peng Koh (Jamaica Plain, MA); Suneet Agarwal (Belmont, MA); Aravind Iyer (Bethesda, MD)
Assignees: Children's Medical Center Corporation; The United States of America, as represented by the Secretary, Department of Health and Human Services
C12Q1/6806C12N5/0018C12N9/0071C12Q1/26C12Q1/6827G01N33/5011G01N33/5308G01N2500/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,447,452
App. No.
13/795,739
Granted
Sep 20, 2016
Kind
B2
Abstract

The present invention provides for novel methods for regulating and detecting the cytosine methylation status of DNA. The invention is based upon identification of a novel and surprising catalytic activity for the family of TET proteins, namely TET1, TET2, TET3, and CXXC4. The novel activity is related to the enzymes being capable of converting the cytosine nucleotide 5-methylcytosine into 5-hydroxymethylcytosine by hydroxylation.

Claims (21)

1. A kit for the detection and purification of methylcytosine and 5-hydroxymethylcytosine for use in downstream applications, the kit comprising:

(a) one or more catalytically active TET family enzymes, functional TET family derivatives, or TET catalytically active fragments thereof for the conversion of methylcytosine to 5-hydroxymethylcytosine;

(b) one or more enzymes encoded by bacteriophages of the “T even” family;

(c) one or more glucose or glucose-derivative donor substrates;

(d) one or more proteins to detect glucose or glucose-derivative modified nucleotides;

(e) standard DNA purification columns, buffers, and substrate solutions; and

(f) packaging materials and instructions therein to use said kits,

wherein the enzyme encoded by bacteriophages of the “T even” family is selected from the group consisting of alpha-glucosyltransferases, beta-glucosyltransferases, and beta-glucosyl-alpha-glucosyl-transferases.

2. The kit of claim 1 , wherein the alpha-glucosyltransferase is encoded by a bacteriophage selected from the group consisting of T2, T4, and T6 bacteriophages.

3. The kit of claim 1 , wherein the beta-glucosyltransferase is encoded by a bacteriophage selected from T4 bacteriophages.

4. The kit of claim 1 , wherein the beta-glucosyl-alpha-glucosyl-transferase is encoded by a bacteriophage selected from the group consisting of T2 and T6 bacteriophages.

5. The kit of claim 1 , wherein the glucose or glucose-derivative donor substrate is uridine diphosphate glucose (UDPG).

6. The kit of claim 1 , wherein the glucose or glucose-derivative donor substrate is radiolabeled.

7. The kit of claim 6 , wherein the uridine diphosphate glucose is radiolabeled with 14C or 3H.

8. The kit of claim 1 , wherein the protein to detect glucose or glucose-derivative modified nucleotides is a lectin, an antibody or an antigen binding fragment thereof, or an enzyme.

9. The kit of claim 8 , wherein the protein recognizes the glucose or glucose-derivative only in the context of 5-hydroxymethylcytosine.

10. The kit of claim 8 , wherein the protein is modified with at least one tag.

11. The kit of claim 10 , wherein the tag is a biotin molecule, a bead, a gold particle, or a fluorescent molecule.

12. The kit of claim 8 , wherein the enzyme is a hexokinase or a beta-glucosyl-alpha-glucosyl-transferase.

13. The kit of claim 8 , wherein the lectin is Musa acuminata lectin (BanLec).

14. The kit of claim 8 , wherein the lectin is modified with a gold particle or a fluorescent tag.

Assignments (7)
CONFIRMATORY LICENSE Recorded Mar 2, 2022
From: BOSTON CHILDREN'S HOSPITAL
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 059292/0465 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2016
From: THE CHILDREN'S HOSPITAL CORPORATION
To: CHILDREN'S MEDICAL CENTER CORPORATION
Reel/Frame 039055/0746 →
MERGER Recorded Jun 28, 2016
From: IMMUNE DISEASE INSTITUTE, INC.
To: THE CHILDREN'S HOSPITAL CORPORATION
Reel/Frame 039027/0407 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE ADDRESS PREVIOUSLY RECORDED AT REEL: 038993 FRAME: 0772. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jun 27, 2016
From: IYER, ARAVIND
To: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 039173/0243 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2016
From: IYER, ARAVIND
To: NATIONAL INSTITUTES OF HEALTH
Reel/Frame 038993/0772 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2016
From: AGARWAL, SUNEET
To: CHILDREN'S MEDICAL CENTER CORPORATION
Reel/Frame 038448/0226 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2016
From: RAO, ANJANA; TAHILIANI, MAMTA; KOH, KIAN PENG
To: IMMUNE DISEASE INSTITUTE, INC.
Reel/Frame 038448/0276 →
Continuity (5)
Continuation 13120861
Provisional Application 61100503 · Sep 26, 2008
Provisional Application 61100995 · Sep 29, 2008
Provisional Application 61121844 · Dec 11, 2008
Related Publication 20130177912A1 · Jul 11, 2013